Ammar Amany S, Mahmoud Khaled M
Department of Anesthesiology, Faculty of Medicine, Minoufiya University, Shebin El Kom, Minoufiya, Egypt.
Saudi J Anaesth. 2012 Jul;6(3):229-33. doi: 10.4103/1658-354X.101213.
Different adjuvants have been used to improve the quality and increase the duration of local anesthetics during various nerve block techniques. The current study was aimed to evaluate the effect of adding dexamethasone to bupivacaine on the quality and duration of transversus abdominis plane (TAP) block.
Sixty adult patients undergoing elective open abdominal hysterectomy were randomly allocated to receive TAP block using 20 mL of bupivacaine hydrochloride 0.25% + 2 mL saline 0.9% (control group, n=30) or 20 mL of bupivacaine hydrochloride 0.25% + 2 mL dexamethasone "8 mg" (dexamethasone group, n=30). The primary outcome was postoperative pain, as evaluated by visual analog scale (VAS) for pain scoring at 1, 2, 4, 12, 24 and 48 h postoperatively, whereas the secondary outcomes were time to first analgesia (TFA), morphine consumption and the occurrence of nausea, vomiting or somnolence.
The pain VAS score was significantly lower at the postoperative 2 h (4.9 vs. 28.1, P=0.01), 4 h (12.2 vs. 31.1, P=0.01) and 12 h (15.7 vs. 25.4, P=0.02). Furthermore, TFA was significantly longer in the dexamethasone group (459.8 vs. 325.4 min, P=0.002), with lesser morphine requirements in the postoperative 48 h (4.9 vs. 21.2 mg, P=0.003) and lower incidence of nausea and vomiting (6 vs. 14, P=0.03). No complications attributed to the block were recorded.
Addition of dexamethasone to bupivacaine in TAP block prolonged the duration of the block and decreased the incidence of nausea and vomiting.
在各种神经阻滞技术中,已使用不同的佐剂来改善局部麻醉药的质量并延长其作用时间。本研究旨在评估在布比卡因中添加地塞米松对腹横肌平面(TAP)阻滞的质量和持续时间的影响。
60例择期行开放性腹部子宫切除术的成年患者被随机分配,分别接受使用20 mL 0.25%盐酸布比卡因+2 mL 0.9%生理盐水的TAP阻滞(对照组,n = 30)或20 mL 0.25%盐酸布比卡因+2 mL地塞米松“8 mg”的TAP阻滞(地塞米松组,n = 30)。主要结局指标为术后疼痛,通过术后1、2、4、12、24和48小时的视觉模拟评分法(VAS)进行疼痛评分,次要结局指标为首次镇痛时间(TFA)、吗啡用量以及恶心、呕吐或嗜睡的发生情况。
术后2小时(4.9对28.1,P = 0.01)、4小时(12.2对31.1,P = 0.01)和12小时(15.7对25.4,P = 0.02)时,地塞米松组的疼痛VAS评分显著更低。此外,地塞米松组的TFA显著更长(459.8对325.4分钟,P = 0.002),术后48小时的吗啡需求量更少(4.9对21.2 mg,P = 0.003),恶心和呕吐的发生率更低(6对14,P = 0.03)。未记录到与阻滞相关的并发症。
在TAP阻滞中,布比卡因添加地塞米松可延长阻滞持续时间并降低恶心和呕吐的发生率。